Top Markets
Coin of the day
Diffusion Pharmaceuticals Inc. Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Inc.

DFFN
Rank in Stocks #31359
As a biopharmaceutical enterprise, Diffusion Pharmaceuticals Inc. concentrates... As a biopharmaceutical enterprise, Diffusion Pharmaceuticals Inc. concentrates on pioneering new treatments that bolster the body's efficiency in oxygen distribution. The company's flagship investigational therapy is Trans Sodium Crocetinate, which is formulated to facilitate the spread of oxygen into tissues. This compound is additionally under development for its application in addressing COVID-19. Headquartered in Charlottesville, Virginia, Diffusion Pharmaceuticals Inc. was established in 2001.
Share Price
$6.60
Last synced: 2023-08-16
Market Cap
$13.46M
Change (1 day)
11.68%
Change (1 year)
0.00%
Country
US
Trade Diffusion Pharmaceuticals Inc. (DFFN)

Category

Operating Margin for Diffusion Pharmaceuticals Inc. (DFFN)
Operating Margin as of 2026 TTM: 0.00%
According to Diffusion Pharmaceuticals Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Diffusion Pharmaceuticals Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
25.72% -
AU
0.00% -
CH
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.